ArticleFrontiers in oncology2025

Natural killer cell as a potential predictive biomarker for early immune checkpoint inhibitor-associated cardiovascular adverse events: a retrospective cohort study.

Yujuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.